Lorenzo Fitzig, M.D. is a cardiovascular disease internal medicine in Rego Park, NY with 46 years of experience. The provider is an internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms. Lorenzo Fitzig, M.D. NPI is 1073519856. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1978
The provider's business location address is:
9901 QUEENS BLVD
REGO PARK, NY
ZIP 11374-512
Phone: (718) 520-6100
Fax: (718) 544-6664
The NPI 1073519856 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Routine ekg using at least 12 leads including interpretation and report (HCPCS:93000)
- Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function (HCPCS:93306)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days (HCPCS:93294)
- Vaccine for influenza for injection into muscle (HCPCS:90662)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report (HCPCS:93280)
- Urinalysis, manual test (HCPCS:81002)
The enumeration date for this NPI number is 6/25/2005 and was last updated on 10/3/2018.